1.Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.
Bing ZHAO ; Chao NI ; Ran GAO ; Yuyan WANG ; Li YANG ; Jinsong WEI ; Ting LV ; Jianqing LIANG ; Qisheng ZHANG ; Wei XU ; Youhua XIE ; Xiaoyue WANG ; Zhenghong YUAN ; Junbo LIANG ; Rong ZHANG ; Xinhua LIN
Protein & Cell 2020;11(10):771-775
		                        		
		                        		
		                        		
		                        			Betacoronavirus
		                        			;
		                        		
		                        			isolation & purification
		                        			;
		                        		
		                        			pathogenicity
		                        			;
		                        		
		                        			Bile Acids and Salts
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Bile Ducts, Intrahepatic
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Cell Culture Techniques
		                        			;
		                        		
		                        			Coronavirus Infections
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Cytokine Release Syndrome
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			physiopathology
		                        			;
		                        		
		                        			Cytopathogenic Effect, Viral
		                        			;
		                        		
		                        			Epithelial Cells
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hyperbilirubinemia
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Organoids
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Peptidyl-Dipeptidase A
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Pneumonia, Viral
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Receptors, Virus
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Serine Endopeptidases
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Viral Load
		                        			
		                        		
		                        	
2.Pilea umbrosa ameliorate CCl induced hepatic injuries by regulating endoplasmic reticulum stress, pro-inflammatory and fibrosis genes in rat.
Irum NAZ ; Muhammad Rashid KHAN ; Jawaid Ahmed ZAI ; Riffat BATOOL ; Zartash ZAHRA ; Aemin TAHIR
Environmental Health and Preventive Medicine 2020;25(1):53-53
		                        		
		                        			BACKGROUND:
		                        			Pilea umbrosa (Urticaceae) is used by local communities (district Abbotabad) for liver disorders, as anticancer, in rheumatism and in skin disorders.
		                        		
		                        			METHODS:
		                        			Methanol extract of P. umbrosa (PUM) was investigated for the presence of polyphenolic constituents by HPLC-DAD analysis. PUM (150 mg/kg and 300 mg/kg) was administered on alternate days for eight weeks in rats exposed with carbon tetrachloride (CCl). Serum analysis was performed for liver function tests while in liver tissues level of antioxidant enzymes and biochemical markers were also studied. In addition, semi quantitative estimation of antioxidant genes, endoplasmic reticulum (ER) induced stress markers, pro-inflammatory cytokines and fibrosis related genes were carried out on liver tissues by RT-PCR analysis. Liver tissues were also studied for histopathological injuries.
		                        		
		                        			RESULTS:
		                        			Level of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), peroxidase (POD) and glutathione (GSH) decreased (p < 0.05) whereas level of thiobarbituric acid reactive substance (TBARS), HO and nitrite increased in liver tissues of CCl treated rat. Likewise increase in the level of serum markers; alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and total bilirubin was observed. Moreover, CCl caused many fold increase in expression of ER stress markers; glucose regulated protein (GRP-78), x-box binding protein1-total (XBP-1 t), x-box binding protein1-unspliced (XBP-1 u) and x-box binding protein1-spliced (XBP-1 s). The level of inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) was aggregated whereas suppressed the level of antioxidant enzymes; γ-glutamylcysteine ligase (GCLC), protein disulfide isomerase (PDI) and nuclear erythroid 2 p45-related factor 2 (Nrf-2). Additionally, level of fibrosis markers; transforming growth factor-β (TGF-β), Smad-3 and collagen type 1 (Col1-α) increased with CCl induced liver toxicity. Histopathological scrutiny depicted damaged liver cells, neutrophils infiltration and dilated sinusoids in CCl intoxicated rats. PUM was enriched with rutin, catechin, caffeic acid and apigenin as evidenced by HPLC analysis. Simultaneous administration of PUM and CCl in rats retrieved the normal expression of these markers and prevented hepatic injuries.
		                        		
		                        			CONCLUSION
		                        			Collectively these results suggest that PUM constituted of strong antioxidant chemicals and could be a potential therapeutic agent for stress related liver disorders.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Carbon Tetrachloride
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			Chemical and Drug Induced Liver Injury
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Endoplasmic Reticulum Stress
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Protective Agents
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			Rats
		                        			;
		                        		
		                        			Rats, Sprague-Dawley
		                        			;
		                        		
		                        			Urticaceae
		                        			;
		                        		
		                        			chemistry
		                        			
		                        		
		                        	
3.Rdh13 deficiency weakens carbon tetrachloride-induced liver injury by regulating Spot14 and Cyp2e1 expression levels.
Xiaofang CUI ; Benting MA ; Yan WANG ; Yan CHEN ; Chunling SHEN ; Ying KUANG ; Jian FEI ; Lungen LU ; Zhugang WANG
Frontiers of Medicine 2019;13(1):104-111
		                        		
		                        			
		                        			Mitochondrion-localized retinol dehydrogenase 13 (Rdh13) is a short-chain dehydrogenase/reductase involved in vitamin A metabolism in both humans and mice. We previously generated Rdh13 knockout mice and showed that Rdh13 deficiency causes severe acute retinal light damage. In this study, considering that Rdh13 is highly expressed in mouse liver, we further evaluated the potential effect of Rdh13 on liver injury induced by carbon tetrachloride (CCl). Although Rdh13 deficiency showed no significant effect on liver histology and physiological functions under regular culture, the Rdh13 mice displayed an attenuated response to CCl-induced liver injury. Their livers also exhibited less histological changes and contained lower levels of liver-related metabolism enzymes compared with the livers of wild-type (WT) mice. Furthermore, the Rdh13 mice had Rdh13 deficiency and thus their liver cells were protected from apoptosis, and the quantity of their proliferative cells became lower than that in WTafter CCl exposure. The ablation of Rdh13 gene decreased the expression levels of thyroid hormone-inducible nuclear protein 14 (Spot14) and cytochrome P450 (Cyp2e1) in the liver, especially after CCl treatment for 48 h. These data suggested that the alleviated liver damage induced by CCl in Rdh13 mice was caused by Cyp2e1 enzymes, which promoted reductive CCl metabolism by altering the status of thyroxine metabolism. This result further implicated Rdh13 as a potential drug target in preventing chemically induced liver injury.
		                        		
		                        		
		                        		
		                        			Alcohol Oxidoreductases
		                        			;
		                        		
		                        			deficiency
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Carbon Tetrachloride Poisoning
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			Chemical and Drug Induced Liver Injury
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Cytochrome P-450 CYP2E1
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, 129 Strain
		                        			;
		                        		
		                        			Mice, Inbred C57BL
		                        			;
		                        		
		                        			Mice, Knockout
		                        			;
		                        		
		                        			Nuclear Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Transcription Factors
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
4.Saeng-Kankunbi-Tang () protects liver against oxidative damage through activation of ERK/Nrf2 pathway.
In Woo LEE ; Hee Yoon CHOI ; Ju-Hee LEE ; Sun-Dong PARK ; Seung Mo KIM ; Sae Kwang KU ; Rong-Jie ZHAO ; Sang Chan KIM ; Young Woo KIM ; Hong Sik CHOI
Chinese journal of integrative medicine 2016;22(8):619-628
OBJECTIVETo investigate the cytoprotective effects of Saeng-kankunbi-tang (, SKT), a herbal prescription consisting of Artemisia capillaris and Alisma canaliculatum, and its underlying mechanism involved.
METHODSIn mice, blood biochemistry and histopathology were assessed in carbon tetrachloride (CCl4)-induced oxidative hepatic injury in vivo. The animal groups included vehicle-treated control, CCl4, SKT 500 mg/(kg day) CCl4+SKT 200 or 500 mg/(kg day). In HepG2 cell, tert-butyl hydroperoxide (tBHP) induced severe oxidative stress and mitochondrial dysfunction in vitro. The cyto-protective effects of SKT were determined by 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) assay, flfluorescence activated cell sorting analysis and western blotting.
RESULTSThe administration of SKT prevented liver damage induced by CCl4 in mice, by inhibition of hepatocyte degeneration and inflflammatory cell infifiltration as well as plasma parameters such as alanine aminotransferase (P<0.01). Moreover, treatment with tBHP induced hepatocyte death and cellular reactive oxygen species production in hepatocyte cell line. However, SKT pretreatment (30-300 μg/mL) reduced this cell death and oxidative stress (P<0.01). More importantly, SKT inhibited the ability of tBHP to induce changes in mitochondrial membrane transition in cell stained with rhodamine 123 P<0.01). Furthermore, treatment with SKT induced extracellular signal-regulated kinases-mediated nuclear factor erythroid-2-related factor 2 (Nrf2) activation as well as the expressions of heme oxygenase 1 and glutamate- cystein ligase catalytic, Nrf2 target genes.
CONCLUSIONSSKT has the ability to protect hepatocyte against oxidative stress and mitochondrial damage mediated by Nrf2 activation.
Animals ; Antioxidants ; pharmacology ; Carbon Tetrachloride ; Cell Death ; drug effects ; Drugs, Chinese Herbal ; pharmacology ; Extracellular Signal-Regulated MAP Kinases ; metabolism ; Hep G2 Cells ; Humans ; Liver ; drug effects ; enzymology ; pathology ; MAP Kinase Signaling System ; drug effects ; Mice, Inbred C57BL ; Mitochondria ; drug effects ; metabolism ; NF-E2-Related Factor 2 ; metabolism ; Oxidative Stress ; drug effects ; Peroxides ; Phosphorylation ; drug effects ; Protective Agents ; pharmacology ; Reactive Oxygen Species ; metabolism
5.Protective effect of emodin pretreatment in young rats with intrahepatic cholestasis.
Xiao-Li XIONG ; Su-Qi YAN ; Huan QIN ; Li-Shan ZHOU ; Ling-Ling ZHANG ; Zhi-Xia JIANG ; Yan DING
Chinese Journal of Contemporary Pediatrics 2016;18(2):165-171
OBJECTIVETo investigate the protective effect of emodin in young rats with intrahepatic cholestasis.
METHODSA total of 120 young Sprague-Dawley rats were randomly divided into control, model, and high-, medium-, and low-dose emodin groups, with 24 rats in each group. The rats in the control and model groups were given sodium carboxymethyl cellulose solution by gavage, while the other groups were given different doses of emodin solution by gavage. On the 5th day of experiment, alpha-naphthylisothiocyanate (ANIT, 50 mg/kg) was applied by gavage to establish the model of intrahepatic cholestasis in all groups except the control group. At 24, 48, and 72 hours after gavage, 8 rats in each group were sacrificed. Colorimetry was used to measure the serum levels of total bilirubin (TBIL), direct bilirubin (DBIL), total bile acid (TBA), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in each group, and hematoxylin-eosin staining was applied to observe the morphological changes of the liver under a light microscope at different time points.
RESULTSCompared with the control group, the model group had significantly increased serum levels of TBIL, DBIL, TBA, ALP, GGT, ALT, and AST at the 24-hour, 48-hour, and 72-hour time points (P<0.01). In the model group, the serum levels of TBIL, DBIL, TBA, ALT, and AST showed varying degrees of increase at 48 hours after establishment of model, compared with the values at 24 and 72 hours (P<0.05). At 24, 48, and 72 hours, the high-, medium-, and low-dose emodin groups had varying degrees of reductions in the serum levels of TBIL and TBA compared with the model group (P<0.05); the high- and low-dose emodin groups had significantly increased serum levels of TBA compared with the medium-dose emodin group (P<0.05). The model group had the most severe pathological changes at 48 hours. Compared with the model group, the high-, medium-, and low-dose emodin groups showed certain improvement in pathological changes of the liver at each time point, and the medium-dose emodin group had better improvement compared with the high- and low-dose emodin groups.
CONCLUSIONSEmodin can effectively improve ANIT-induced intrahepatic cholestasis in young rats, and medium-dose emodin shows the best effect.
Alanine Transaminase ; genetics ; metabolism ; Animals ; Aspartate Aminotransferases ; genetics ; metabolism ; Bilirubin ; metabolism ; Cholestasis, Intrahepatic ; drug therapy ; genetics ; metabolism ; pathology ; Drugs, Chinese Herbal ; administration & dosage ; Emodin ; administration & dosage ; Female ; Humans ; Liver ; enzymology ; pathology ; Male ; Rats ; Rats, Sprague-Dawley
6.A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway.
Jesmin MONDAL ; Jayeeta DAS ; Rajesh SHAH ; Anisur Rahman KHUDA-BUKHSH
Journal of Integrative Medicine 2016;14(3):209-218
OBJECTIVEHomeopathic nosodes have seldom been scientifically validated for their anticancer effects. This study was conducted to examine if a recently developed hepatitis C nosode has demonstrable anticancer potential in cancer cells in vitro.
METHODSAnticancer effects of Hepatitis C 30C (Hep C 30), if any, were initially tested on three cancer cell lines, HepG2 (liver cancer), MCF-7 (breast cancer) and A549 (lung cancer) and one normal liver cell line WRL-68 cells and subsequently a more thorough study using further scientific protocols was undertaken on HepG2 cells (against WRL-68 cells as the normal control) as HepG2 cells showed better anticancer response than the other two. Three doses, one at 50% lethal dose (LD50) and the other two below LD50, were used on HepG2 cells subsequently. Protocols like apoptosis induction and its possible signaling mechanism were deployed using immunoblots of relevant signal proteins and confocal microscopy, with particular reference to telomerase and topoisomerase II (Top II) activities, two strong cancer biomarkers for their direct relationship with divisional activities of cells and DNAs.
RESULTSHep C 30 induced apoptosis, caused distorted cell morphology typical of apoptotic cells, increased reactive oxygen species generation and produced increased DNA nicks. Further it enhanced pro-apototic signal proteins like Bax, cytochrome c and inhibited anti-apoptotic signal proteins, Bcl-2, cytochrome c and caspase-3, changed mitochondrial membrane potential and caused externalization of phosphatidylserine. The drug also decreased expression of two cancer biomarkers, Top II and telomerase, consistent with its anticancer effect.
CONCLUSIONHep C 30 has demonstrable anticancer effects against liver cancer cells in vitro.
Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Cell Survival ; drug effects ; DNA Topoisomerases, Type II ; metabolism ; Hep G2 Cells ; Hepacivirus ; Humans ; Liver Neoplasms ; drug therapy ; enzymology ; pathology ; Materia Medica ; Mitochondria ; drug effects ; physiology ; Telomerase ; metabolism
7.Pathological Lesions and Inducible Nitric Oxide Synthase Expressions in the Liver of Mice Experimentally Infected with Clonorchis sinensis.
Qing Li YANG ; Ji Qing SHEN ; Yan XUE ; Xiao Bing CHENG ; Zhi Hua JIANG ; Yi Chao YANG ; Ying Dan CHEN ; Xiao Nong ZHOU
The Korean Journal of Parasitology 2015;53(6):777-783
		                        		
		                        			
		                        			The nitric oxide (NO) formation and intrinsic nitrosation may be involved in the possible mechanisms of liver fluke-associated carcinogenesis. We still do not know much about the responses of inducible NO synthase (iNOS) induced by Clonorchis sinensis infection. This study was conducted to explore the pathological lesions and iNOS expressions in the liver of mice with different infection intensity levels of C. sinensis. Extensive periductal inflammatory cell infiltration, bile duct hyperplasia, and fibrosis were commonly observed during the infection. The different pathological responses in liver tissues strongly correlated with the infection intensity of C. sinensis. Massive acute spotty necrosis occurred in the liver parenchyma after a severe infection. The iNOS activity in liver tissues increased, and iNOS-expressing cells with morphological differences were observed after a moderate or severe infection. The iNOS-expressing cells in liver tissues had multiple origins.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Clonorchiasis/*enzymology/genetics/parasitology/*pathology
		                        			;
		                        		
		                        			Clonorchis sinensis/*physiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver/*enzymology/parasitology/pathology
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred BALB C
		                        			;
		                        		
		                        			Nitric Oxide Synthase Type II/*genetics/metabolism
		                        			
		                        		
		                        	
8.Anticancer effect of total annonaceous acetogenins on hepatocarcinoma.
Run-mei YANG ; Wen-min LI ; Wei-jun HU ; Wen-hua HUANG ; Chun-yan ZHU ; Jing-guang YU ; Xin ZHAO ; Da-yong CAI ; Nan-nan GAO
Chinese journal of integrative medicine 2015;21(9):682-688
OBJECTIVETo confirm the anticancer effect of total annonaceous acetogenins (TAAs) abstracted from Annona squamosa Linn. on human hepatocarcinoma.
METHODSThe inhibitory effect of TAAs was demonstrated in H22-bearing mice. The potency of TAAs was confirmed as its 50% inhibiting concentration (IC50) on Bel-7402 cell under Sulfur Rhodamine B staining. Both underlying mechanisms were explored as cellular apoptosis and cell cycle under flow cytometry. Mitochondrial and recipient apoptotic pathways were differentiated as mitochondrial membrane potential under flow cytometry and caspases activities under fluorescence analysis.
RESULTSThe inhibitory rate of TAAs in mice was 50.98% at 4 mg/kg dose. The IC50 of TAAs on Bel-7402 was 20.06 µg/mL (15.13-26.61µg/mL). Effective mechanisms of TAAs were confirmed as both of arresting cell cycle at G1 phase and inducing apoptosis dose- and time-dependently. Mitochondrial and recipient pathways involved in apoptotic actions of TAAs.
CONCLUSIONTAAs is effective for hepatocarcinoma, via inhibiting proliferation and inducing apoptosis.
Acetogenins ; chemistry ; pharmacology ; therapeutic use ; Animals ; Annona ; chemistry ; Antineoplastic Agents, Phytogenic ; chemistry ; pharmacology ; therapeutic use ; Apoptosis ; drug effects ; Carcinoma, Hepatocellular ; drug therapy ; enzymology ; pathology ; Caspases ; metabolism ; Cell Cycle ; drug effects ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Chromatography, High Pressure Liquid ; Dose-Response Relationship, Drug ; Humans ; Liver Neoplasms ; drug therapy ; enzymology ; pathology ; Male ; Membrane Potential, Mitochondrial ; drug effects ; Mice ; Organ Specificity ; drug effects ; Spleen ; drug effects ; Thymus Gland ; drug effects ; Xenograft Model Antitumor Assays
9.Dan-gua fang improves glycolipid metabolic disorders by promoting hepatic adenosine 5'-monophosphate activated protein kinase expression in diabetic Goto-Kakizaki rats.
Yuan-long LAN ; Su-ping HUANG ; Xian-pei HENG ; Ling CHEN ; Peng-hui LI ; Jing WU ; Liu-qing YANG ; Xu-dong PAN ; Tong LIN ; Xin-ling CHENG ; Qing LIN ; Si-xin CHEN
Chinese journal of integrative medicine 2015;21(3):188-195
OBJECTIVETo investigate the effect of Dan-gua Fang on adenosine 5'-monophosphate (AMP) activated protein kinase (AMPK) α expression in liver and subsequent improvement of glucose and lipid metabolism.
METHODSForty 13-week-old diabetic Goto-Kakizaki (GK) rats were randomly divided into model, Dan-gua Fang, metformin and simvastatin groups (n=10 for each), and fed high-fat diet ad libitum. Ten Wistar rats were used as normal group and fed normal diet. After 24 weeks, liver expression of AMPKα mRNA was assessed by real-time PCR. AMPKα and phospho-AMPKα protein expression in liver was evaluated by Western blot. Liver histomorphology was carried out after hematoxylin-eosin staining, and blood glucose (BG), glycosylated hemoglobin A1c (HbA1c), food intake and body weight recorded.
RESULTSSimilar AMPKα mRNA levels were found in the Dan-gua Fang group and normal group, slightly higher than the values obtained for the remaining groups (P<0.05). AMPKα protein expression in the Dan-gua Fang group animals was similar to other diabetic rats, whereas phospho-AMPKα (Thr-172) protein levels were markedly higher than in the metformin group and simvastatin group (P<0.05), respectively. However, phosphor-AMPKα/AMPKα ratios were similar in all groups. Dan-gua Fang reduced fasting blood glucose with similar strength to metformin, and was superior in reducing cholesterol, triglycerides, high-density lipoprotein cholesterol as well as improving low-density lipoprotein cholesterol in comparison with simvastatin and metformin. Dan-gua Fang decreases plasma alanine aminotransferase (ALT) significantly.
CONCLUSIONDan-gua Fang, while treating phlegm-stasis, could decrease BG and lipid in type 2 diabetic GK rats fed with high-fat diet, and effectively protect liver histomorphology and function. This may be partly explained by increased AMPK expression in liver. Therefore, Dan-gua Fang might be an ideal drug for comprehensive intervention for glucose and lipid metabolism disorders in type 2 diabetes mellitus.
AMP-Activated Protein Kinases ; genetics ; metabolism ; Animals ; Blood Glucose ; metabolism ; Body Weight ; Diabetes Mellitus, Experimental ; blood ; drug therapy ; enzymology ; metabolism ; Drugs, Chinese Herbal ; therapeutic use ; Feeding Behavior ; Glycolipids ; metabolism ; Liver ; enzymology ; pathology ; Male ; Phosphorylation ; RNA, Messenger ; genetics ; metabolism ; Rats, Wistar ; Real-Time Polymerase Chain Reaction ; Time Factors
10.A Case of Autoimmune Hepatitis Combined with Graves' Disease.
Jong Hyun JHEE ; Hyun Ju KIM ; Wonseok KANG ; Sewha KIM ; Do Young KIM
The Korean Journal of Gastroenterology 2015;65(1):48-51
		                        		
		                        			
		                        			A 25-year-old woman presented with jaundice, palpitation, and weight loss of 5 kg during a period of 2 weeks. Laboratory tests showed elevated levels of liver enzymes (AST 1,282 IU/L, ALT 1,119 IU/L) and total bilirubin (6.4 mg/dL); negative for hepatitis virus infection; elevated serum levels of triiodothyronine (T3, 3.60 ng/dL), free thyroxine (fT4, 3.82 ng/dL), and lowered serum level of thyroid stimulating hormone (TSH, <0.025 microIU/mL); and positive for thyroid stimulating antibody and anti-mitochondrial antibody (AMA). The liver biopsy findings were consistent with autoimmune hepatitis (AIH). Accordingly, oral steroid therapy was started with 60 mg of prednisolone under the impression of AIH associated with Graves' disease. After a week of steroid therapy, the clinical manifestation showed significant improvement, with normalization of both liver and thyroid functions. Diagnosis of the liver condition of patients who present with hyperthyroidism and liver dysfunction is important, so that appropriate therapy can be promptly initiated.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Alanine Transaminase/analysis
		                        			;
		                        		
		                        			Antibodies, Antinuclear/blood
		                        			;
		                        		
		                        			Aspartate Aminotransferases/analysis
		                        			;
		                        		
		                        			Bilirubin/blood
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Graves Disease/complications/*diagnosis/drug therapy
		                        			;
		                        		
		                        			Hepatitis, Autoimmune/complications/*diagnosis/drug therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulins, Thyroid-Stimulating/blood
		                        			;
		                        		
		                        			Liver/enzymology/metabolism/pathology
		                        			;
		                        		
		                        			Prednisolone/therapeutic use
		                        			;
		                        		
		                        			Steroids/therapeutic use
		                        			;
		                        		
		                        			Thyrotropin/blood
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail